about
Experimental treatment of antipsychotic-induced movement disordersDetection of dopaminergic supersensitivity induced by neuroleptic drugs in miceTardive dyskinesia: therapeutic options for an increasingly common disorder.Sulpiride in tardive dyskinesiaA comparison of purposeless movements in psychiatric patients treated with antipsychotic drugs, and normal individualsWhat happens in the leucotomised brain? A postmortem morphological study of brains from schizophrenic patientsTopographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.Orofacial dyskinesia. Clinical features, mechanisms and drug therapyClinical aspects of dyskinesiaEthical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.Abnormal involuntary movements: side-effect of neuroleptic drugs.An update on tardive dyskinesia: from phenomenology to treatmentTransitory procaine-induced Parkinsonism.ECT and tardive dyskinesia.Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment.Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials.Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management.Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients.Tardive dyskinesia: an evaluation of the etiologic association with neuroleptic therapy.Unusual morphology of scapulae: incidence and dimensions of ossified ligaments and supraspinous bony tunnels for clinical consideration.Psychotropic drugs--neurotoxicity.[Tardive dyskinesia: a current review]Sudden death in phenothiazine therapy. (A clinicopathologic study of 12 cases).Chronic deep brain stimulation in patients with tardive dystonia without a history of major psychosis.Neuroradiological covariates of drug-induced parkinsonism and tardive dyskinesia in schizophrenia.Valbenazine for the treatment of tardive dyskinesia.Clinical features, etiology and treatment of facial dyskinesias in the elderly.Tardive dyskinesia in psychiatric patients with substance use disorders.The current status of tardive dyskinesia
P2860
Q26740354-45E4C625-8C4C-414B-BE8F-A83724D40D98Q28260250-6E8B8C0A-99EA-4AE9-9020-F45B2B1899B6Q30566749-988D774A-5B63-44F0-9332-028EC18D9432Q33589103-4C4385B6-31E1-4EE1-8230-2AD158004743Q33618840-342C8F0E-FA4C-49BF-AEE5-5FCE4D02B29DQ33629667-3BC1606C-D943-42C1-984E-DD6BE0D9CB06Q33630401-53E95BCD-434A-4267-A59C-45C17BE0D0BEQ34050289-1D27B5A8-AB94-4F71-8CD1-4BDA37D40D8FQ34453589-FDE19D2E-9D63-41C2-92F1-7C8D56A12BEEQ35693061-F7079DE5-C657-483D-90C1-8097123F136BQ36553039-3342DF01-8823-450A-84FA-B93F8D4DE4A4Q37006021-5A8F9102-BC4F-4DE0-BFA5-66F57789BA4AQ37074890-50376CDD-F27A-4F7D-99FD-C1CD15DFEE4BQ37599311-F1C573A4-50CC-4491-904A-6662BBC808CDQ37868985-F932DC68-6A9D-4A7A-901D-AD7726EDA4A7Q38306593-01500D3C-9095-49D8-8860-097BDA0B53F7Q38545655-F934A60E-B1FA-420C-8376-0078F137D385Q38657158-5F81C624-3E08-4B2F-8B94-A2D3FB3F9C7AQ38819771-23DC25C9-B099-411C-BA00-E008721036A1Q39951009-2F7BE65A-C457-49AC-9549-52F4CC4D1BB8Q40036273-3B8557A1-9C60-4D2B-A57F-CBB266B2EA65Q40291186-77839CD6-B102-4B7F-9F4E-0E5F1A453701Q41347800-9151B390-A385-4BFB-81BC-C29BBA529A90Q42238905-F5CFA829-C520-4476-B21D-089081982D0FQ42970938-EE2C3B71-FB40-4D8C-A951-F509C64ADF96Q45098438-E2C92CAE-ECC3-45C1-BDD6-EA127F7A2AD1Q47670227-B7DBA01D-BA2F-44B4-9286-51B4BB6C747AQ48511485-9F93653A-DD0E-4E8B-A378-F03D510D0C61Q52061337-6AE3F6F3-AC82-4548-A392-0847EB647FC4Q57725386-32B0FC17-767D-48DF-BBA2-E690CCD71857
P2860
description
1964 nî lūn-bûn
@nan
1964 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1964 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1964年の論文
@ja
1964年論文
@yue
1964年論文
@zh-hant
1964年論文
@zh-hk
1964年論文
@zh-mo
1964年論文
@zh-tw
1964年论文
@wuu
name
NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.
@ast
NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.
@en
type
label
NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.
@ast
NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.
@en
prefLabel
NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.
@ast
NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.
@en
P2093
P2860
P1476
NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.
@en
P2093
BRANDBORG G
PAKKENBERG H
PETERSEN PB
P2860
P356
10.1111/J.1600-0447.1964.TB05731.X
P407
P577
1964-01-01T00:00:00Z